NYSE:PAH - Platform Specialty Products Stock Price, News, & Analysis

Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH."

Platform Specialty Products Corp (NYSE:PAH) posted its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 EPS for the quarter, topping the Zacks' consensus estimate of $0.24 by $0.02. The specialty chemicals company earned $1 billion during the quarter, compared to the consensus estimate of $997.27 million. Platform Specialty Products had a positive return on equity of 8.48% and a negative net margin of 14.14%. The company's revenue for the quarter was up 6.5% compared to the same quarter last year. During the same period last year, the firm earned $0.20 earnings per share. View Platform Specialty Products' Earnings History.

Platform Specialty Products updated its FY 2019 earnings guidance on Monday, January, 28th. The company provided earnings per share (EPS) guidance of $0.75-0.80 for the period, compared to the Thomson Reuters consensus estimate of $0.73. Platform Specialty Products also updated its FY 2018 guidance to EPS.

6 brokerages have issued 1 year target prices for Platform Specialty Products' shares. Their predictions range from $12.00 to $15.00. On average, they anticipate Platform Specialty Products' share price to reach $13.25 in the next twelve months. This suggests a possible upside of 25.4% from the stock's current price. View Analyst Price Targets for Platform Specialty Products.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Platform Specialty Products.

News headlines about PAH stock have been trending positive this week, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Platform Specialty Products earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days.

Some companies that are related to Platform Specialty Products include Versum Materials (VSM), Element Solutions (ESI), Cabot (CBT), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Platform Specialty Products investors own include Micron Technology (MU), Alibaba Group (BABA), Two Harbors Investment (TWO), Uniti Group (UNIT), Fitbit (FIT), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), Intel (INTC), General Electric (GE) and Kratos Defense & Security Solutions (KTOS).

Platform Specialty Products' stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (9.91%), BlackRock Inc. (5.74%), Dimensional Fund Advisors LP (5.50%), Gates Capital Management Inc. (2.33%), Vaughan Nelson Investment Management L.P. (1.41%) and Victory Capital Management Inc. (1.26%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products.

PAH stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Wedge Capital Management L L P NC, First Manhattan Co., First Trust Advisors LP, Raymond James & Associates, Victory Capital Management Inc., Van ECK Associates Corp and ETF Managers Group LLC. Company insiders that have sold Platform Specialty Products company stock in the last year include Martin E Franklin and Pershing Square Capital Manage. View Insider Buying and Selling for Platform Specialty Products.

PAH stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Consulta Ltd, Locust Wood Capital Advisers LLC, Vaughan Nelson Investment Management L.P., Gates Capital Management Inc., Royce & Associates LP, Hsbc Holdings PLC and BlackRock Inc.. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Insider Buying and Selling for Platform Specialty Products.

Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PAH stock can currently be purchased for approximately $10.57.

Platform Specialty Products has a market capitalization of $3.05 billion and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis.

The official website for Platform Specialty Products is http://www.platformspecialtyproducts.com.

Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at (561) 207-9600.